Doccheck Ag Stock Price To Earning

AJ91 Stock  EUR 8.00  0.05  0.62%   
DocCheck AG fundamentals help investors to digest information that contributes to DocCheck's financial success or failures. It also enables traders to predict the movement of DocCheck Stock. The fundamental analysis module provides a way to measure DocCheck's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DocCheck stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

DocCheck AG Company Price To Earning Analysis

DocCheck's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current DocCheck Price To Earning

    
  18.89 X  
Most of DocCheck's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DocCheck AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, DocCheck AG has a Price To Earning of 18.89 times. This is 31.76% lower than that of the Technology sector and 50.64% lower than that of the Health Information Services industry. The price to earning for all Germany stocks is 34.23% higher than that of the company.

DocCheck Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DocCheck's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DocCheck could also be used in its relative valuation, which is a method of valuing DocCheck by comparing valuation metrics of similar companies.
DocCheck is currently under evaluation in price to earning category among its peers.

DocCheck Fundamentals

About DocCheck Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DocCheck AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DocCheck using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DocCheck AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in DocCheck Stock

DocCheck financial ratios help investors to determine whether DocCheck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DocCheck with respect to the benefits of owning DocCheck security.